Part 1/6:
Breakthrough in AI-Driven Drug Discovery: A New Era for Treating Pulmonary Fibrosis
In an unprecedented development, scientists have successfully utilized artificial intelligence (AI) to create a new drug candidate that is now moving into human clinical trials. This milestone marks one of the first instances where AI has been employed at such a fundamental level in drug development, potentially revolutionizing how future medicines are designed and brought to market.